Aquestive Therapeutics Inc (AQST)
3.095
-0.20
(-6.07%)
USD |
NASDAQ |
May 10, 16:00
3.07
-0.02
(-0.81%)
After-Hours: 20:00
Aquestive Therapeutics Price: 3.095 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 3.10 | 3.42 | 3.00 | 3.295 | 2.057M |
| May 08, 2024 | 3.18 | 3.23 | 2.91 | 3.085 | 2.748M |
| May 07, 2024 | 3.44 | 3.50 | 3.295 | 3.38 | 1.575M |
| May 06, 2024 | 3.56 | 3.60 | 3.41 | 3.50 | 1.068M |
| May 03, 2024 | 3.30 | 3.54 | 3.26 | 3.52 | 1.706M |
| May 02, 2024 | 3.40 | 3.410 | 3.205 | 3.28 | 1.680M |
| May 01, 2024 | 3.35 | 3.47 | 3.20 | 3.365 | 2.104M |
| Apr 30, 2024 | 3.59 | 3.65 | 3.06 | 3.36 | 4.011M |
| Apr 29, 2024 | 3.91 | 3.950 | 3.24 | 3.735 | 7.648M |
| Apr 26, 2024 | 4.00 | 4.250 | 3.95 | 4.07 | 2.987M |
| Apr 25, 2024 | 3.93 | 4.01 | 3.775 | 3.93 | 1.936M |
| Apr 24, 2024 | 4.25 | 4.280 | 3.90 | 3.90 | 2.148M |
| Apr 23, 2024 | 4.38 | 4.50 | 4.24 | 4.28 | 1.700M |
| Apr 22, 2024 | 4.18 | 4.39 | 4.01 | 4.38 | 1.826M |
| Apr 19, 2024 | 4.38 | 4.54 | 4.05 | 4.105 | 2.341M |
| Apr 18, 2024 | 4.00 | 4.51 | 3.93 | 4.50 | 5.785M |
| Apr 17, 2024 | 3.94 | 4.05 | 3.82 | 3.92 | 2.448M |
| Apr 16, 2024 | 3.88 | 3.89 | 3.72 | 3.85 | 1.887M |
| Apr 15, 2024 | 4.05 | 4.10 | 3.83 | 3.94 | 1.345M |
| Apr 12, 2024 | 4.07 | 4.11 | 3.75 | 3.91 | 3.512M |
| Apr 11, 2024 | 4.34 | 4.38 | 4.075 | 4.09 | 2.848M |
| Apr 10, 2024 | 4.00 | 4.145 | 3.984 | 4.07 | 1.187M |
| Apr 09, 2024 | 4.06 | 4.165 | 3.93 | 4.09 | 1.665M |
| Apr 08, 2024 | 4.10 | 4.15 | 3.96 | 4.07 | 1.373M |
| Apr 05, 2024 | 4.19 | 4.295 | 3.99 | 4.10 | 2.216M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.63
Minimum
Jul 01 2022
9.09
Maximum
Sep 11 2020
3.413
Average
3.53
Median
Aug 14 2019
Price Benchmarks
| Lifecore Biomedical Inc | 6.296 |
| Harrow Inc | 11.60 |
| Akebia Therapeutics Inc | 1.21 |
| 89bio Inc | 8.71 |
| Geron Corp | 3.805 |
Price Related Metrics
| PS Ratio | 4.024 |
| Earnings Yield | -4.98% |
| Market Cap | 226.87M |